SEC Filings

10-Q
ENVISION HEALTHCARE CORP filed this Form 10-Q on 08/08/2017
Entire Document
 
Item 1. Financial Statements - (continued)

Envision Healthcare Corporation
Consolidated Statements of Cash Flows (unaudited)
(In millions)
 
Six Months Ended June 30,
 
2017
 
2016
Cash flows from operating activities:
 

 
 
Net earnings (loss)
$
(283.2
)
 
$
187.8

Adjustments to reconcile net earnings (loss) to net cash flows provided by operating activities:
 
 
 
Depreciation and amortization
211.8

 
59.1

Amortization of deferred loan costs
8.4

 
4.2

Provision for uncollectibles
2,510.9

 
207.0

Net (gain) loss on disposals and deconsolidations
5.5

 
(2.6
)
Share-based compensation
29.3

 
15.1

Deferred income taxes
529.3

 
21.0

Equity in earnings of unconsolidated affiliates
(10.9
)
 
(14.0
)
Impairment charges
0.3

 

Net change in fair value of contingent consideration

 
(2.6
)
Other, net

 
(3.7
)
Increases (decreases) in cash and cash equivalents, net of acquisitions and dispositions:
 
 
 
Accounts receivable
(2,577.9
)
 
(228.3
)
Supplies inventory
(0.7
)
 
(0.4
)
Prepaid and other current assets
(5.1
)
 
(23.7
)
Accounts payable
(6.1
)
 
(3.3
)
Accrued expenses and other liabilities
(45.4
)
 
(28.2
)
Other, net
12.5

 
7.6

Net cash flows provided by operating activities
378.7

 
195.0

Cash flows from investing activities:
 
 
 
Acquisitions and related expenses, net of cash acquired
(485.7
)
 
(281.1
)
Acquisition of property and equipment
(90.7
)
 
(37.6
)
Purchases of marketable securities
(15.9
)
 
(0.5
)
Maturities of marketable securities
7.0

 
2.7

Other, net
(5.2
)
 
(8.7
)
Net cash flows used in investing activities
(590.5
)
 
(325.2
)
Cash flows from financing activities:
 
 
 
Proceeds from long-term borrowings
798.3

 
317.1

Repayment on long-term borrowings
(314.3
)
 
(98.8
)
Distributions to noncontrolling interests
(119.0
)
 
(115.6
)
Proceeds from issuance of common stock upon exercise of stock options
3.7

 
0.5

Repurchase of common stock
(8.9
)
 
(5.6
)
Financing costs incurred
(2.9
)
 

Other, net
(12.1
)
 

Net cash flows provided by financing activities
344.8

 
97.6

Net increase (decrease) in cash and cash equivalents
133.0

 
(32.6
)
Cash and cash equivalents, beginning of period
331.6

 
106.7

Less cash and cash equivalents of held for sale assets, end of period
23.3

 

Cash and cash equivalents, end of period
$
441.3

 
$
74.1


See accompanying notes to the unaudited consolidated financial statements.
5